Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids

Arthritis & Rheumatism

Volumn 37, Issue 10, 1994, Pages 1499-1505

  Hall, Gerard M ^a   Daniels, Maxine ^a   Doyle, David V ^a   Spector, Tim D ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM LACTOGLUCONATE; CORTICOSTEROID; ESTRADIOL; MEDROXYPROGESTERONE ACETATE PLUS ESTRADIOL; NORETHISTERONE; PREMPAK; SANDOCAL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUMBAR SPINE; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STEROID THERAPY;

ADRENAL CORTEX HORMONES; AGE FACTORS; ARTHRITIS, RHEUMATOID; BONE DENSITY; CALCIUM; COMPARATIVE STUDY; ESTROGEN REPLACEMENT THERAPY; FEMALE; FEMUR; HUMAN; LUMBAR VERTEBRAE; MIDDLE AGE; POSTMENOPAUSE; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T;

EID: 0028079813     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780371014     Document Type: Article

References (45)

1. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women.
2. Relationship between local and total bone mineral in patients with rheumatoid arthritis and normal subjects.
3. Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment.
4. Bone mineral density in patients with recent onset rheumatoid arthritis: inflence of disease activity and functional capacity.
5. Determinants of axial bone loss in rheumatoid arthritis.
6. Risk of vertebral fracture in women with rheumatoid arthritis.
7. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal ptients with rheumatoid arthritis: effect of low dose corticsteroids.
8. Bone minere content in patients with rheumatoid arthritis: relationship to low‐dose steroid therapy.
9. Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy.
10. Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids.
11. Low dose prednisone does not effect calcium homeostasis or bone density in postmenopausal women with rheumatoid arthritis.
12. Long‐term prevention of postmenopausal osteoporosis by estrogen.
13. Reversal of postmenopausal vertebral bone loss by estrogen and progestogen: a double blind placebo controlled study.
14. 17B estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
15. Treatment of postmenopausal osteoporosis with transdermal estrogen.
16. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen.
17. Long‐term estrogen replacement prevents bone loss and fractures.
18. Adjuvant estrogen treatment increases bone mineral density in postmentopausal women with rheumatoid arthritis.
19. Measurement of patient outcome in arthritis.
20. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.
21. Baseline measurements of bone mass predicts fracture in white women.
22. Appendicular bone density and age predict hip fracture in women.
23. Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women.
24. Postmenopausal bone loss in rheumatoid arthritis: effect of estrogens and androgens.
25. Estrogen therapy arrests bone loss in elderly women.
26. Steroid‐induced fractures and bone loss in patients with asthma.
27. Steroid osteoporosis.
28. Glucocorticoid induced osteoporosis: pathogenesis and management.
29. Is steroid induced osteoporosis preventable
30. Estrogen and progesterone replacement therapy reduces glucocorticoid‐induced bone loss.
31. Cytoplasmic glucocorticoid binding proteins in bone cells.
32. A randomised controlled trial of hormone replacement therapy in postmenopausal rheumatoid arthritis.
33. Compliance with hormone replacement therapy after screening for postmenopausal osteoporosis.
34. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis.
35. Calcitonin for the prevention of postmenopausal bone loss.
36. Intranasal calcitonin for the prevention of bone erosion and bone loss in rheumatoid arthritis.
37. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women.
38. Effect of calcium supplementation on bone loss in postmenopausal women.
39. Does calcium supplementation prevent postmenopausal bone loss? A double blind controlled clinical study.
40. Calcium supplements in the prevention of steroid‐induced osteoporosis.
41. Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol and calcitonin.
42. Calcium absorption in rheumatoid arthritis.
43. Generalised bone loss in patients with early rheumatoid arthritis.